ArticleJHEP reports : innovation in hepatology2023

MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis.

Luis Antonio Díaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.